questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Métalloprotéines
Protéines de liaison au fer
Protéines à fer non hème
Lipoxygénases
Arachidonate lipoxygenases
Arachidonate 5-lipoxygenase
Arachidonate 5-lipoxygenase : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Lipoxygenases
Leucotriènes
Imagerie par résonance magnétique
Inflammation
Tests génétiques
Mutations
Symptômes
5
Asthme
Réactions allergiques
Crise d'asthme
Oppression thoracique
Prévention
5
Prévention de l'asthme
Allergènes
Régime alimentaire
Inflammation
Gestion du stress
Méditation
Exercice physique
Fonction pulmonaire
Traitements
5
Inhibiteurs de la lipoxygénase
Asthme
Anti-inflammatoires
Médiateurs
Acides gras oméga-3
Antioxydants
Corticostéroïdes
Réponse immunitaire
Bronchodilatateurs
Voies respiratoires
Complications
5
Infections respiratoires
Hospitalisations
Inflammation chronique
Maladies cardiovasculaires
Asthme
Dommages pulmonaires
Qualité de vie
Activités physiques
Facteurs de risque
5
Antécédents familiaux
Pollution
Tabagisme
Complications respiratoires
Infections respiratoires
Crises d'asthme
Exposition professionnelle
Irritants
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Arachidonate 5-lipoxygenase : Questions médicales les plus fréquentes",
"headline": "Arachidonate 5-lipoxygenase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Arachidonate 5-lipoxygenase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-12",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Arachidonate 5-lipoxygenase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Arachidonate lipoxygenases",
"url": "https://questionsmedicales.fr/mesh/D001091",
"about": {
"@type": "MedicalCondition",
"name": "Arachidonate lipoxygenases",
"code": {
"@type": "MedicalCode",
"code": "D001091",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.556.579.374.568.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Arachidonate 5-lipoxygenase",
"alternateName": "Arachidonate 5-Lipoxygenase",
"code": {
"@type": "MedicalCode",
"code": "D001094",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Dieter Steinhilber",
"url": "https://questionsmedicales.fr/author/Dieter%20Steinhilber",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt/Main, Germany."
}
},
{
"@type": "Person",
"name": "Ann-Kathrin Häfner",
"url": "https://questionsmedicales.fr/author/Ann-Kathrin%20H%C3%A4fner",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt/Main, Germany."
}
},
{
"@type": "Person",
"name": "Oliver Werz",
"url": "https://questionsmedicales.fr/author/Oliver%20Werz",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University, Jena, Germany."
}
},
{
"@type": "Person",
"name": "Hartmut Kuhn",
"url": "https://questionsmedicales.fr/author/Hartmut%20Kuhn",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany."
}
},
{
"@type": "Person",
"name": "Ulrike Garscha",
"url": "https://questionsmedicales.fr/author/Ulrike%20Garscha",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University, Jena, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[Chronic constipation].",
"datePublished": "2024-10-22",
"url": "https://questionsmedicales.fr/article/39437823",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2194-3285"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of constipation in patients undergoing chemotherapy and the effect of constipation on quality of life.",
"datePublished": "2022-06-28",
"url": "https://questionsmedicales.fr/article/35761103",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00520-022-07244-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence and Burden of Illness of Rome IV Chronic Idiopathic Constipation, Opioid-Induced Constipation, and Opioid-Exacerbated Constipation in the United States.",
"datePublished": "2023-06-19",
"url": "https://questionsmedicales.fr/article/37335135",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14309/ajg.0000000000002376"
}
},
{
"@type": "ScholarlyArticle",
"name": "Constipation in Parkinson's Disease.",
"datePublished": "2023-08-14",
"url": "https://questionsmedicales.fr/article/37579786",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0043-1771457"
}
},
{
"@type": "ScholarlyArticle",
"name": "Constipation in transverse myelitis.",
"datePublished": "2023-03-06",
"url": "https://questionsmedicales.fr/article/36878618",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2022-254409"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Métalloprotéines",
"item": "https://questionsmedicales.fr/mesh/D008667"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de liaison au fer",
"item": "https://questionsmedicales.fr/mesh/D033862"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines à fer non hème",
"item": "https://questionsmedicales.fr/mesh/D019159"
},
{
"@type": "ListItem",
"position": 7,
"name": "Lipoxygénases",
"item": "https://questionsmedicales.fr/mesh/D058945"
},
{
"@type": "ListItem",
"position": 8,
"name": "Arachidonate lipoxygenases",
"item": "https://questionsmedicales.fr/mesh/D001091"
},
{
"@type": "ListItem",
"position": 9,
"name": "Arachidonate 5-lipoxygenase",
"item": "https://questionsmedicales.fr/mesh/D001094"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Arachidonate 5-lipoxygenase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Arachidonate 5-lipoxygenase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Arachidonate 5-lipoxygenase",
"description": "Comment diagnostiquer une dysfonction de l'enzyme ?\nQuels examens sont utilisés pour évaluer l'inflammation ?\nY a-t-il des tests génétiques pour l'arachidonate 5-lipoxygenase ?\nQuels symptômes indiquent un problème avec cette enzyme ?\nComment évaluer l'activité de l'enzyme dans le corps ?",
"url": "https://questionsmedicales.fr/mesh/D001094?mesh_terms=Constipation#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Arachidonate 5-lipoxygenase",
"description": "Quels sont les symptômes d'une surproduction de leucotriènes ?\nComment l'inflammation se manifeste-t-elle ?\nY a-t-il des signes d'allergies liés à cette enzyme ?\nQuels symptômes sont associés à l'asthme ?\nComment reconnaître une crise d'asthme ?",
"url": "https://questionsmedicales.fr/mesh/D001094?mesh_terms=Constipation#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Arachidonate 5-lipoxygenase",
"description": "Comment prévenir les crises d'asthme ?\nY a-t-il des mesures diététiques à prendre ?\nComment gérer le stress pour prévenir l'inflammation ?\nQuels exercices sont bénéfiques pour les asthmatiques ?\nComment éviter les irritants environnementaux ?",
"url": "https://questionsmedicales.fr/mesh/D001094?mesh_terms=Constipation#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Arachidonate 5-lipoxygenase",
"description": "Quels médicaments ciblent l'arachidonate 5-lipoxygenase ?\nComment les anti-inflammatoires aident-ils ?\nY a-t-il des traitements naturels disponibles ?\nQuels sont les effets des corticostéroïdes ?\nComment les bronchodilatateurs agissent-ils ?",
"url": "https://questionsmedicales.fr/mesh/D001094?mesh_terms=Constipation#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Arachidonate 5-lipoxygenase",
"description": "Quelles complications peuvent survenir avec l'asthme ?\nComment l'inflammation chronique affecte-t-elle la santé ?\nY a-t-il des risques de développement d'allergies ?\nQuels sont les effets à long terme de l'asthme non contrôlé ?\nComment l'asthme peut-il affecter la vie quotidienne ?",
"url": "https://questionsmedicales.fr/mesh/D001094?mesh_terms=Constipation#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Arachidonate 5-lipoxygenase",
"description": "Quels sont les facteurs de risque pour l'asthme ?\nComment le tabagisme influence-t-il l'asthme ?\nY a-t-il un lien entre l'obésité et l'asthme ?\nQuels rôles jouent les infections respiratoires ?\nComment l'exposition professionnelle affecte-t-elle l'asthme ?",
"url": "https://questionsmedicales.fr/mesh/D001094?mesh_terms=Constipation#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction de l'enzyme ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins peuvent mesurer les niveaux de leucotriènes et d'autres biomarqueurs."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer l'inflammation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie, l'IRM et les tests de laboratoire peuvent aider à évaluer l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests génétiques pour l'arachidonate 5-lipoxygenase ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent identifier des mutations affectant l'enzyme, mais ils sont rares."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec cette enzyme ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'asthme, les allergies ou des maladies inflammatoires peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'activité de l'enzyme dans le corps ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques mesurent l'activité de l'enzyme dans des échantillons de tissus ou de sang."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une surproduction de leucotriènes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des crises d'asthme, des réactions allergiques et des inflammations chroniques."
}
},
{
"@type": "Question",
"name": "Comment l'inflammation se manifeste-t-elle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'inflammation peut se manifester par des rougeurs, des douleurs, un gonflement et une chaleur locale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'allergies liés à cette enzyme ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des démangeaisons, des éruptions cutanées et des difficultés respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à l'asthme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la toux, la respiration sifflante, l'essoufflement et la pression thoracique."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une crise d'asthme ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une crise d'asthme se manifeste par une respiration difficile, une toux persistante et une oppression thoracique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les crises d'asthme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les allergènes, utiliser des médicaments préventifs et suivre un plan d'action personnalisé."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures diététiques à prendre ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fruits, légumes et oméga-3 peut aider à réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Comment gérer le stress pour prévenir l'inflammation ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de gestion du stress comme la méditation et le yoga peuvent réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels exercices sont bénéfiques pour les asthmatiques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exercices modérés comme la marche ou la natation peuvent améliorer la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment éviter les irritants environnementaux ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez la fumée, la pollution et les produits chimiques irritants pour protéger vos voies respiratoires."
}
},
{
"@type": "Question",
"name": "Quels médicaments ciblent l'arachidonate 5-lipoxygenase ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inhibiteurs de la lipoxygénase, comme le zileuton, sont utilisés pour traiter l'asthme."
}
},
{
"@type": "Question",
"name": "Comment les anti-inflammatoires aident-ils ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils réduisent l'inflammation en inhibant la production de leucotriènes et d'autres médiateurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels disponibles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des acides gras oméga-3 et des antioxydants peuvent aider à moduler l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels sont les effets des corticostéroïdes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes réduisent l'inflammation et la réponse immunitaire, soulageant les symptômes."
}
},
{
"@type": "Question",
"name": "Comment les bronchodilatateurs agissent-ils ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils dilatent les voies respiratoires, facilitant la respiration et réduisant les symptômes d'asthme."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'asthme ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des infections respiratoires, des crises d'asthme sévères et des hospitalisations."
}
},
{
"@type": "Question",
"name": "Comment l'inflammation chronique affecte-t-elle la santé ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'inflammation chronique peut entraîner des maladies cardiovasculaires et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de développement d'allergies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition prolongée à des allergènes peut augmenter le risque de développer des allergies."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme de l'asthme non contrôlé ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'asthme non contrôlé peut entraîner des dommages pulmonaires permanents et une qualité de vie réduite."
}
},
{
"@type": "Question",
"name": "Comment l'asthme peut-il affecter la vie quotidienne ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'asthme peut limiter les activités physiques, affecter le sommeil et entraîner des absences scolaires ou professionnelles."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour l'asthme ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, l'exposition à des allergènes et la pollution sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Comment le tabagisme influence-t-il l'asthme ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme aggrave les symptômes d'asthme et augmente le risque de complications respiratoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre l'obésité et l'asthme ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité est un facteur de risque qui peut aggraver les symptômes et la gravité de l'asthme."
}
},
{
"@type": "Question",
"name": "Quels rôles jouent les infections respiratoires ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections respiratoires peuvent déclencher des crises d'asthme et aggraver l'inflammation."
}
},
{
"@type": "Question",
"name": "Comment l'exposition professionnelle affecte-t-elle l'asthme ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition à des irritants ou allergènes au travail peut augmenter le risque d'asthme professionnel."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 06/04/2025
Contenu vérifié selon les dernières recommandations médicales
7 publications dans cette catégorie
Affiliations :
Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt/Main, Germany.
6 publications dans cette catégorie
Affiliations :
Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt/Main, Germany.
6 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University, Jena, Germany.
6 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.
5 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University, Jena, Germany.
Publications dans "Arachidonate 5-lipoxygenase" :
4 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.
Publications dans "Arachidonate 5-lipoxygenase" :
4 publications dans cette catégorie
Affiliations :
Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, 60438 Frankfurt, Germany.
Publications dans "Arachidonate 5-lipoxygenase" :
4 publications dans cette catégorie
Affiliations :
Department of Integrative Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea.
Publications dans "Arachidonate 5-lipoxygenase" :
4 publications dans cette catégorie
Affiliations :
Department of Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea. deokkun@konkuk.ac.kr.
Department of Integrative Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea. deokkun@konkuk.ac.kr.
Publications dans "Arachidonate 5-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama, 719-1197, Japan.
Publications dans "Arachidonate 5-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama, 719-1197, Japan.
Publications dans "Arachidonate 5-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama, 719-1197, Japan.
Publications dans "Arachidonate 5-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama, 719-1197, Japan. Electronic address: toshiko@fhw.oka-pu.ac.jp.
Publications dans "Arachidonate 5-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Otolaryngology, Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730 People's Republic of China.
Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, 100005 People's Republic of China.
Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730 People's Republic of China.
Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences, Beijing, 100005 People's Republic of China.
Publications dans "Arachidonate 5-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Division of Clinical Pharmacology, Department of Pharmacology, and Vanderbilt Institute of Chemical Biology, Vanderbilt University Medical School, Nashville, Tennessee 37232, United States.
Publications dans "Arachidonate 5-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Institute for Clinical Pharmacology, Goethe University, Medical Faculty, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.
Publications dans "Arachidonate 5-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Straße 9, 60438 Frankfurt, Germany.
Publications dans "Arachidonate 5-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Publications dans "Arachidonate 5-lipoxygenase" :
2 publications dans cette catégorie
Affiliations :
Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama, 719-1197, Japan.
Publications dans "Arachidonate 5-lipoxygenase" :
2 publications dans cette catégorie
Affiliations :
Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama, 719-1197, Japan.
Publications dans "Arachidonate 5-lipoxygenase" :
Chronic constipation is one of the most common health disorders in all of medicine. Its extent ranges from mild discomfort, which is usually easy to improve, to severe functional limitations that may ...
This study was conducted as a descriptive and cross-sectional study to determine the prevalence of constipation and the impact of constipation on quality of life in patients receiving outpatient chemo...
The data of the study were collected from 252 patients who applied to the outpatient chemotherapy unit of a university hospital between January 2021 and March 2021. The data were collected using the "...
The constipation prevalence of the patients included in the study was 31.7% and the mean constipation severity score was 30.48 ± 13.87. It was found that the quality of life of the patients due to con...
Constipation occurs in one-third of cancer patients receiving ambulatory chemotherapy. The severity of constipation in patients is at a moderate level and it impacts the quality of life moderately....
Chronic idiopathic constipation (CIC) and opioid-induced constipation (OIC) are disorders that negatively affect quality of life. We sought to assess the prevalence, symptom severity, and medication u...
From May 3, 2020, to June 24, 2020, we recruited a representative sample of people in the United States ≥ 18 years to complete an online national health survey. The survey guided participants through ...
Among the 88,607 participants, 5,334 (6.0%) had Rome IV CIC, and 1,548 (1.7%) and 335 (0.4%) had Rome IV OIC and OEC, respectively. When compared with people with CIC (Patient-Reported Outcome Measure...
In this nationwide US survey, we found that Rome IV CIC is common (6.0%) while Rome IV OIC (1.7%) and OEC (0.4%) are less prevalent. Individuals with OIC and OEC have a higher burden of illness with r...
Constipation is one of the most common gastrointestinal features of Parkinson's disease (PD), occurring in over 50% of all PD patients during the course of their disease. Furthermore, constipation is ...
Transverse myelitis is an extremely rare neuroinflammatory disorder. About half of the affected patients develop paraplegia associated with urinary and bowel dysfunction. The bowel dysfunction is thou...
To evaluate whether providing a constipation action plan (CAP) to families of children with constipation at outpatient gastroenterology (GI) visits affects health care utilization of the GI department...
We created a CAP to be included in the after visit summary of children seen in our GI Clinic. We compared the number of patient telephone calls, electronic messages, and urgent care (UC) visits, emerg...
We included 336 patients who received the CAP and 2812 who did not. After IPTW adjustment, there were fewer patient telephone calls for patients who received the CAP (P = 0.0006). The difference in pa...
We found that providing a CAP to families of children with constipation decreases health care utilization. Further studies are needed to determine whether this impacts patient outcomes....
Patients with chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) often experience severe symptoms. The current aim was to evaluate plecanatide in adults with ...
Data were analyzed post hoc from randomized, placebo-controlled trials (CIC [n = 2], IBS-C [n = 2]) of plecanatide 3 mg, 6 mg, or placebo administered for 12 weeks. Severe constipation was defined as ...
Severe constipation was observed in 24.5% (646/2639) and 24.2% (527/2176) of CIC and IBS-C populations, respectively. The CIC durable overall CSBM response rate (plecanatide 3 mg, 20.9%; plecanatide 6...
Plecanatide was effective in the treatment of severe constipation in adults with CIC or IBS-C....
To implement and to evaluate the effectiveness of the Uniformed Services Constipation Action Plan (USCAP) in our gastroenterology clinic for children with functional constipation....
This implementation science study included toilet-trained subjects aged 4 years and older who met the Rome IV criteria for functional constipation. Children were block randomized to receive either the...
Fifty-seven treatment group subjects (44%) received a USCAP (52% male; mean age, 10.9 [4.9] years) compared with 73 controls (56%; 48% male; mean age,10.9 [5.3] years). A PBSFS score of 3 or 4 was ach...
The USCAP is a simple, inexpensive tool that has the potential to improve global outcomes for functional constipation in children and should be recommended as standard clinical practice....
Constipation encompasses symptoms of decreased colonic motility or difficulty with the defecation process. As a broad definition, this can be inclusive of functional constipation (FC) or colonic inert...
Constipation can seriously affect the quality of life and increase the risk of colorectal cancer. The present strategies for constipation therapy have adverse effects, such as causing irreversible int...